The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.

iX Biopharma faces scrutiny over Orion licence and US$41 million Wafermine contract

Nov 5, 2026 05:35 (2h ago)

Verifying

iX Biopharma clarified Orion’s Nevada licence and unsigned US joint venture after SGX queries.
US$41 million covers Wafermine’s military contract for emergency-use work and clinical trials.
Wafermine’s emergency-use submission is targeted within the next 12 months, according to iX Biopharma.